Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases
Authors:
- Marka van BlitterswijkMBMarka van Blitterswijk
- Mark H.B. HuismanMHMark H.B. Huisman
- Lotte VlamLVLotte Vlam
- Perry T.C. van DoormaalPDPerry T.C. van Doormaal
- Meinie SeelenMSMeinie Seelen
- Jelena MedicJMJelena Medic
- Dennis DooijesDDDennis Dooijes
- Marianne de VisserMVMarianne de Visser
- Anneke J. van der KooiAKAnneke J. van der Kooi
- Joost RaaphorstJRJoost Raaphorst
- Helenius J. SchelhaasHSHelenius J. Schelhaas
- 28 August 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 79 (9) , 878-882
Abstract
Objective: To assess the frequency and phenotype of hexanucleotide repeat expansions in C9ORF72 in a large cohort of patients of Dutch descent with familial (fALS) and sporadic (sALS) amyotrophic lateral sclerosis (ALS), progressive muscular atrophy (PMA), and primary lateral sclerosis (PLS). Methods: Included were 78 patients with fALS, 1,422 with sALS, 246 with PMA, and 110 with PLS, and 768 control subjects. Repeat expansions were determined by a repeat primed PCR. Familial aggregation of dementia and Parkinson disease (PD) was examined among patients with ALS who carried the repeat expansion. Results: The expanded repeat was found in 33 (37%) of all patients with fALS, in 87 (6.1%) patients with sALS, in 4 (1.6%) patients with PMA, and in 1 (0.9%) patient with PLS. None of the controls carried the mutation. Patients with ALS with the repeat expansion had an earlier age at onset (median 59.3 vs 61.9 years, hazard ratio 1.55, p = 5 × 10−5) and shorter survival (median 2.5 vs 2.7 years, hazard ratio 1.46, p = 8 × 10−4). Dementia, but not PD, occurred nearly twice as often in relatives of patients with the expansion compared to all patients with ALS or controls (p = 9 × 10−4). Conclusions: The hexanucleotide repeat expansion in C9ORF72 is a major cause of fALS and apparently sporadic ALS in the Netherlands. Patients who carry the repeat expansion have an earlier onset, shorter survival, and familial aggregation of dementia. These results challenge the classic definition of fALS and may justify genetic testing in patients with sALS.Keywords
This publication has 18 references indexed in Scilit:
- Repeat Expansion inC9ORF72in Alzheimer's DiseaseNew England Journal of Medicine, 2012
- The chromosome 9 ALS and FTD locus is probably derived from a single founderNeurobiology of Aging, 2012
- Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72Acta Neuropathologica, 2011
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTDNeuron, 2011
- Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial DiseaseHuman Heredity, 2011
- Amyotrophic lateral sclerosisThe Lancet, 2011
- Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2009
- Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosisNature Genetics, 2009
- Instability of a premutation allele in homozygous patients with myotonic dystrophy type 1Annals of Neurology, 2002